Literature DB >> 16380991

Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer.

Eliane Kellen1, Maurice Zeegers, Aimée Paulussen, Martien Van Dongen, Frank Buntinx.   

Abstract

We have hypothesized that consumption of fruit and vegetables may be associated with reduced risk of bladder cancer and that this may interact with cigarette smoking and metabolic genetic polymorphisms. A population-based case-control study was performed in the Belgian province of Limburg among 200 cases and 385 controls. Logistic regression was performed to calculate odds ratios (ORs) for bladder cancer occurrence with corresponding 95% confidence intervals (95% CI). Effect modification by smoking was investigated. We also evaluated interaction between fruit intake and GSTM1, GSTT1, NAT2 and SULT1A1 amongst "ever-smokers." Total vegetable intake was not significantly associated with the risk of bladder cancer (OR 1.15, 95% CI: 0.70-1.88 for the highest compared to the lowest tertile). However, total fruit intake was negatively associated with bladder cancer risk (OR 0.61, 95% CI 0.37-0.99 comparing the same tertiles). Among individuals with low daily fruit consumption, ever smokers had a highly increased risk of bladder cancer risk (OR: 4.23, 95% CI: 1.91-9.40). By increasing the daily fruit consumption, the risk of "ever-smokers" for developing bladder cancer decreased, however it remained significant (OR: 2.15; 95CI%: 1.15-4.05). No interaction was identified between the different genotypes and fruit consumption. We conclude that fruit consumption may decrease the effect of smoking on developing bladder cancer. Antioxidants, found in fruit, may protect against the damage caused by free radicals found in cigarette smoke. Metabolic polymorphisms appear not to modify this relation. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16380991     DOI: 10.1002/ijc.21714

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  [Prevention of uro-oncological diseases].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

2.  Differential methylation pattern of xenobiotic metabolizing genes and susceptibility to Balkan endemic nephropathy, in a cohort of Romanian patients.

Authors:  Alexandra Ivan; Dilys Lam; Mirabela Iustina Cristea; Ada Telea; Alexandra Teodora Gruia; Camelia Oprean; Florin Margineanu; Florina Maria Bojin; Richard Saffery; Virgil Paunescu; Calin Adrian Tatu
Journal:  J Nephrol       Date:  2019-06-20       Impact factor: 3.902

3.  European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Authors:  Thorunn Rafnar; Sita H Vermeulen; Patrick Sulem; Gudmar Thorleifsson; Katja K Aben; J Alfred Witjes; Anne J Grotenhuis; Gerald W Verhaegh; Christina A Hulsbergen-van de Kaa; Soren Besenbacher; Daniel Gudbjartsson; Simon N Stacey; Julius Gudmundsson; Hrefna Johannsdottir; Hjordis Bjarnason; Carlo Zanon; Hafdis Helgadottir; Jon Gunnlaugur Jonasson; Laufey Tryggvadottir; Eirikur Jonsson; Gudmundur Geirsson; Sigfus Nikulasson; Vigdis Petursdottir; D Timothy Bishop; Sei Chung-Sak; Ananya Choudhury; Faye Elliott; Jennifer H Barrett; Margaret A Knowles; Petra J de Verdier; Charlotta Ryk; Annika Lindblom; Peter Rudnai; Eugene Gurzau; Kvetoslava Koppova; Paolo Vineis; Silvia Polidoro; Simonetta Guarrera; Carlotta Sacerdote; Angeles Panadero; José I Sanz-Velez; Manuel Sanchez; Gabriel Valdivia; Maria D Garcia-Prats; Jan G Hengstler; Silvia Selinski; Holger Gerullis; Daniel Ovsiannikov; Abdolaziz Khezri; Alireza Aminsharifi; Mahyar Malekzadeh; Leonard H van den Berg; Roel A Ophoff; Jan H Veldink; Maurice P Zeegers; Eliane Kellen; Jacopo Fostinelli; Daniele Andreoli; Cecilia Arici; Stefano Porru; Frank Buntinx; Abbas Ghaderi; Klaus Golka; José I Mayordomo; Giuseppe Matullo; Rajiv Kumar; Gunnar Steineck; Anne E Kiltie; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson; Lambertus A Kiemeney
Journal:  Hum Mol Genet       Date:  2011-07-12       Impact factor: 6.150

Review 4.  Sulfotransferase genetic variation: from cancer risk to treatment response.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Drug Metab Rev       Date:  2013-09-06       Impact factor: 4.518

5.  Association between the SULT1A1 Arg213His polymorphism and the risk of bladder cancer: a meta-analysis.

Authors:  Chih-Ming Su; Mei-Chieh Chen; I-Chan Lin; Hsin-An Chen; Ming-Te Huang; Chih-Hsiung Wu; Kun-Hung Shen; Yuan-Hung Wang
Journal:  Tumour Biol       Date:  2014-04-25

6.  CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer.

Authors:  Sofia Pavanello; Giuseppe Mastrangelo; Donatella Placidi; Marcello Campagna; Alessandra Pulliero; Angela Carta; Cecilia Arici; Stefano Porru
Journal:  Eur J Epidemiol       Date:  2010-06-18       Impact factor: 8.082

7.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

Review 8.  [Primary prevention of bladder cancer. What's new?].

Authors:  J E Altwein
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

9.  Fruit and vegetable intakes are associated with lower risk of bladder cancer among women in the Multiethnic Cohort Study.

Authors:  Song-Yi Park; Nicholas J Ollberding; Christy G Woolcott; Lynne R Wilkens; Brian E Henderson; Laurence N Kolonel
Journal:  J Nutr       Date:  2013-06-05       Impact factor: 4.798

10.  Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study.

Authors:  Maree T Brinkman; Margaret R Karagas; Michael Scott Zens; Alan Schned; Raoul C Reulen; Maurice P Zeegers
Journal:  Cancer Causes Control       Date:  2009-12-31       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.